Novartis (China) (Q331535): Difference between revisions

From geokb

Latest revision as of 14:39, 10 September 2024

company organization in Beijing, China

北京诺华制药有限公司

Language	Label	Description	Also known as
English	Novartis (China)	company organization in Beijing, China	北京诺华制药有限公司

Statements

0 references

addresses subject

Epigenetic Modifications and Their Functional Implications

61

1 reference

https://openalex.org/I4210091341

Reciprocal Development of TH17 and Treg Cells

59

1 reference

https://openalex.org/I4210091341

54

1 reference

https://openalex.org/I4210091341

Protein Arginine Methylation in Mammals

39

1 reference

https://openalex.org/I4210091341

Atopic Dermatitis and Skin Microbiome

39

1 reference

https://openalex.org/I4210091341

Health Economics and Quality of Life Assessment

36

1 reference

https://openalex.org/I4210091341

Computational Methods in Drug Discovery

35

1 reference

https://openalex.org/I4210091341

Pathogenesis and Treatment of Pemphigoid Diseases

33

1 reference

https://openalex.org/I4210091341

Management of Hypertension and Cardiovascular Risk Factors

32

1 reference

https://openalex.org/I4210091341

Therapeutic Antibodies: Development, Engineering, and Applications

29

1 reference

https://openalex.org/I4210091341

Developmental Pharmacology in Pediatric Drug Use

27

1 reference

https://openalex.org/I4210091341

Advancements in Lung Cancer Research

25

1 reference

https://openalex.org/I4210091341

Diagnosis and Management of Urticaria

24

1 reference

https://openalex.org/I4210091341

Cancer Immunotherapy

24

1 reference

https://openalex.org/I4210091341

Genomic Landscape of Cancer and Mutational Signatures

24

1 reference

https://openalex.org/I4210091341

Principles and Applications of Green Chemistry

23

1 reference

https://openalex.org/I4210091341

Immunobiology of Dendritic Cells

23

1 reference

https://openalex.org/I4210091341

Efficacy and Resistance in CML Treatment

21

1 reference

https://openalex.org/I4210091341

Economics of Pharmaceutical Research and Development

21

1 reference

https://openalex.org/I4210091341

Regulation of Chromatin Structure and Function

21

1 reference

https://openalex.org/I4210091341

Age-Related Macular Degeneration Research

21

1 reference

https://openalex.org/I4210091341

Genomic Aberrations and Treatment of Chronic Lymphocytic Leukemia

20

1 reference

https://openalex.org/I4210091341

Standardisation and Management of COPD

20

1 reference

https://openalex.org/I4210091341

Diagnosis and Treatment of Heart Failure

19

1 reference

https://openalex.org/I4210091341

Role of Histone Deacetylases in Cellular Regulation

18

1 reference

https://openalex.org/I4210091341

coordinate location

40°12'26"N, 116°14'2"E

1 reference

https://openalex.org/I4210091341

People's Republic of China

1 reference

https://openalex.org/I4210091341

official website

https://www.novartis.com

1 reference

https://openalex.org/I4210091341

0 references

Research Organization Registry ID

0 references

is subsidiary of

Novartis (Switzerland)

1 reference

https://openalex.org/I4210091341

Retrieved from "https://geokb.wikibase.cloud/w/index.php?title=Item:Q331535&oldid=1267955"